Document is current

Article History

Received: 2 August 2020

Revised: 5 October 2020

Accepted: 9 October 2020

First Online: 23 October 2020

Compliance with ethical standards

:

: AA reports financial activities for consulting from Gilead, Genfit, Sterotherapeutics, and Connect, for consulting and speaking from Intercept, for advisory board membership from SanyalBio, all outside the submitted work. DD reports grants and personal fees from Gilead, grants and personal fees from Abbvie, grants and personal fees from Intercept, outside the submitted work. MWS reports advisory board fees from Bayer, Eisai, Exelixis, all outside the submitted work; JML reports grants and personal fees from Bayer Pharmaceuticals, Eisai Inc., Bristol Myers Squibb, Boehringer-Ingelheim, and Ipsen, personal fees from Merck, Celsion, Eli Lilly, Roche, Genentech, Glycotest, Nucleix, Can-Fite Biopharma, Exelixis, and Astrazeneca, all outside the submitted work. AV reports personal fees from NGM Pharmaceuticals, Gilead, Nucleix, Fuji Wako, Guidepoint, Exact Sciences, all outside the submitted work. All remaining authors have nothing to declare in regard to this manuscript.